ES8102134A1 - Procedimiento para preparar derivados de acido acetico - Google Patents

Procedimiento para preparar derivados de acido acetico

Info

Publication number
ES8102134A1
ES8102134A1 ES488651A ES488651A ES8102134A1 ES 8102134 A1 ES8102134 A1 ES 8102134A1 ES 488651 A ES488651 A ES 488651A ES 488651 A ES488651 A ES 488651A ES 8102134 A1 ES8102134 A1 ES 8102134A1
Authority
ES
Spain
Prior art keywords
compound
general formula
antimicrobial agents
formula
cephalosporin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488651A
Other languages
English (en)
Spanish (es)
Other versions
ES488651A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH154579A external-priority patent/CH641810A5/de
Priority claimed from CH17480A external-priority patent/CH645378A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES488651A0 publication Critical patent/ES488651A0/es
Publication of ES8102134A1 publication Critical patent/ES8102134A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES488651A 1979-02-16 1980-02-15 Procedimiento para preparar derivados de acido acetico Expired ES8102134A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH154579A CH641810A5 (en) 1979-02-16 1979-02-16 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH17480A CH645378A5 (en) 1980-01-10 1980-01-10 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them

Publications (2)

Publication Number Publication Date
ES488651A0 ES488651A0 (es) 1980-12-16
ES8102134A1 true ES8102134A1 (es) 1980-12-16

Family

ID=25683752

Family Applications (2)

Application Number Title Priority Date Filing Date
ES488651A Expired ES8102134A1 (es) 1979-02-16 1980-02-15 Procedimiento para preparar derivados de acido acetico
ES497002A Granted ES497002A0 (es) 1979-02-16 1980-11-20 Procedimiento para preparar derivados de acido acetico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES497002A Granted ES497002A0 (es) 1979-02-16 1980-11-20 Procedimiento para preparar derivados de acido acetico

Country Status (19)

Country Link
US (1) US4477448A (enExample)
AT (1) AT374806B (enExample)
CA (1) CA1161032A (enExample)
DE (1) DE3005012A1 (enExample)
DK (1) DK53780A (enExample)
ES (2) ES8102134A1 (enExample)
FI (1) FI800381A7 (enExample)
FR (1) FR2449093A1 (enExample)
GB (2) GB2046734B (enExample)
IE (1) IE49395B1 (enExample)
IL (1) IL59391A (enExample)
IT (1) IT8047922A0 (enExample)
MY (1) MY8500128A (enExample)
NL (1) NL8000894A (enExample)
NZ (1) NZ192873A (enExample)
PH (1) PH17926A (enExample)
PT (1) PT70834A (enExample)
SE (2) SE8000982L (enExample)
YU (1) YU40280A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037380B1 (en) * 1980-03-28 1984-09-12 BIOCHEMIE Gesellschaft m.b.H. New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
CH648038A5 (de) * 1981-01-19 1985-02-28 Sandoz Ag 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung.
GB2125033B (en) * 1982-07-23 1985-08-29 Servipharm Ltd Cephalosporins
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
US5688964A (en) * 1996-02-13 1997-11-18 Eastman Kodak Company Process for preparing a acylhyrazino pyrazole derivative
ATE268990T1 (de) * 1999-09-24 2004-07-15 Agro Kanesho Co Ltd Insektizide und akarizide
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins

Also Published As

Publication number Publication date
MY8500128A (en) 1985-12-31
FR2449093A1 (fr) 1980-09-12
IL59391A0 (en) 1980-05-30
GB2046734B (en) 1983-09-01
YU40280A (en) 1983-06-30
IL59391A (en) 1983-05-15
FI800381A7 (fi) 1981-01-01
SE8500589D0 (sv) 1985-02-08
NZ192873A (en) 1984-07-31
GB2117774B (en) 1984-03-21
NL8000894A (nl) 1980-08-19
ES8203848A1 (es) 1982-04-01
ES488651A0 (es) 1980-12-16
PT70834A (en) 1980-03-01
ATA78780A (de) 1983-10-15
FR2449093B1 (enExample) 1983-07-29
IE800284L (en) 1980-08-16
CA1161032A (en) 1984-01-24
AT374806B (de) 1984-06-12
PH17926A (en) 1985-01-31
US4477448A (en) 1984-10-16
SE8000982L (sv) 1980-08-17
GB8309730D0 (en) 1983-05-18
IE49395B1 (en) 1985-10-02
DK53780A (da) 1980-08-17
IT8047922A0 (it) 1980-02-15
GB2117774A (en) 1983-10-19
GB2046734A (en) 1980-11-19
DE3005012A1 (de) 1980-11-27
ES497002A0 (es) 1982-04-01

Similar Documents

Publication Publication Date Title
ES8102134A1 (es) Procedimiento para preparar derivados de acido acetico
CA592758A (en) Dehydrochlorination of dichloropropionic acid compounds
CA591461A (en) Process for the manufacture of olefinic compounds by the dehydrochlorination of corresponding chlorinated derivatives
CA594693A (en) Process for the manufacture of olefinic compounds by the dehydrochlorination of corresponding chlorinated derivatives
CA601369A (en) Production of oxygenated organic compounds
CA607753A (en) Production of oxygenated organic compounds
FR1250163A (fr) Procédé de préparation de sels d'acides sulfo-sulfiniques organiques ainsi que de sels d'acides disulfoniques organiques
AU259745B2 (en) Process forthe preparation of substituted succinic acid compounds
CA520802A (en) Synthesis of oxygenated organic compounds
GB541375A (en) Improvements in and relating to the manufacture of cyanoacrylic acid esters
CA602705A (en) Process for the production of new derivatives of mucic acid
CA603184A (en) Process of producing glutaric acid compounds
CA550456A (en) Process for the isomerization of unsaturated fatty acid compounds
AU224689B2 (en) Process forthe preparation of gluconic., acid monohydrate anda new compound as such
GB602078A (en) Manufacture of stable supersaturated solutions of saccharide derivatives of compounds of the suprarenal cortex hormone series
AU100561A (en) Process forthe preparation of substituted succinic acid compounds
CA609942A (en) Production of polyolefinic acyloxy compounds
CA595537A (en) Oxidative cleavage of aliphatic compounds
AU252044B2 (en) Process forthe production of alkyl phenols by alkylation of phenols with alcohol
CA605503A (en) Preparation of organic titanium compounds
AU255620B2 (en) Process forthe preparation of olefinic compounds containing two or more double bonds
AU216407B2 (en) Parasiticidal compounds based onn-alkylamides of o, o-dialkydithiophosphorylacetic acids
AU245936B2 (en) Process forthe manufacture of derivatives of 2, 3-dimethoxy 5-methyl-benzohydroquinone-(1
AU267968B2 (en) Process forthe production of new alkyl benzoic acid derivatives
AU267225B2 (en) Sulphonation of organic compounds